Revive Toric RWE Study

ConditionAstigmatism

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorBausch & Lomb Incorporated

About this trial

This is a post-market observational clinical investigation. The objective of this observational study is to evaluate the visual performance and HCP satisfaction of REVIVE samfilcon B custom toric contact lenses.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Be 18 years or older on the date the ICF is signed

Have the capacity to read, understand, and provide written voluntary informed consent

Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings

Have no active ocular disease or allergic conjunctivitis

Disqualifiers

Is participating in another research study

Is considered by the Investigator to not be a suitable candidate for participation

Is not eligible for treatment with the study lens per the IFU (contraindicated)

Has had previous ocular surgery

Trial population

Patient population at study site locations

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

REVIVE samfilcon B custom toric contact lenses
Device
REVIVE samfilcon B custom toric contact lenses

Treatment groups

30 Participants

are divided into 1 treatment group

Group A: REVIVE samfilcon B custom toric contact lenses1 intervention

Trial outcomes

Primary outcomes

Investigator overall satisfaction as assessed by the Investigator Survey

(completed by the Investigator for each subject at 14 days ± 3 days after the final dispensing/refinement visit)

Time frame

Assessed 14 days ± 3 days after the final dispensing/refinement visit

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Bausch & Lomb Incorporated

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: